Home
HALO
HALO News

Latest Halozyme Therapeutics Inc. (HALO) News on July 27, 2024

Here's Why Halozyme Therapeutics (HALO) is a Strong Growth Stock

Zacks

11 hours ago

Here's Why Halozyme Therapeutics (HALO) is a Strong Growth Stock

This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar

Zacks

11 hours ago

This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar

MT Newswires

2 days ago

Halozyme Therapeutics Insider Sold Shares Worth $1,100,023, According to a Recent SEC Filing

Argus Research

3 days ago

HALO: What does Argus have to say about HALO?

MT Newswires

3 days ago

Halozyme Therapeutics Insider Sold Shares Worth $269,662, According to a Recent SEC Filing

Why Halozyme Therapeutics (HALO) is a Top Value Stock for the Long-Term

Zacks

3 days ago

Why Halozyme Therapeutics (HALO) is a Top Value Stock for the Long-Term

Zacks.com featured highlights include Amazon.com, Halozyme Therapeutics, Tenet Healthcare and Atmos Energy

Zacks

3 days ago

Zacks.com featured highlights include Amazon.com, Halozyme Therapeutics, Tenet Healthcare and Atmos Energy

Halozyme to Report Second Quarter 2024 Financial and Operating Results

PR Newswire

3 days ago

Halozyme to Report Second Quarter 2024 Financial and Operating Results

J&J (JNJ) Q2 Earnings & Sales Top, EPS View Cut on M&A Costs

Zacks

9 days ago

J&J (JNJ) Q2 Earnings & Sales Top, EPS View Cut on M&A Costs

Argus Research

10 days ago

HALO: Raising target price to $58.00

Big Money Eyes Halozyme for Strong Growth

FX Empire

10 days ago

Big Money Eyes Halozyme for Strong Growth

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Zacks

10 days ago

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Top Medical Stocks to Buy for Growth & Performance

Zacks

16 days ago

Top Medical Stocks to Buy for Growth & Performance

How to Find Strong Buy Medical Stocks Using the Zacks Rank

Zacks

16 days ago

How to Find Strong Buy Medical Stocks Using the Zacks Rank

If You Invested $1000 in Halozyme Therapeutics a Decade Ago, This is How Much It'd Be Worth Now

Zacks

16 days ago

If You Invested $1000 in Halozyme Therapeutics a Decade Ago, This is How Much It'd Be Worth Now

Argus Research

17 days ago

HALO: Raising target price to $56.00

Is Halozyme Therapeutics (HALO) a Solid Growth Stock? 3 Reasons to Think "Yes"

Zacks

17 days ago

Is Halozyme Therapeutics (HALO) a Solid Growth Stock? 3 Reasons to Think "Yes"

Why Halozyme Therapeutics (HALO) is a Top Growth Stock for the Long-Term

Zacks

18 days ago

Why Halozyme Therapeutics (HALO) is a Top Growth Stock for the Long-Term

How Small Biotech Halozyme, With A 41% Run, Is Getting Under Your Skin

Investor's Business Daily

24 days ago

How Small Biotech Halozyme, With A 41% Run, Is Getting Under Your Skin

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Zacks

a month ago

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

MT Newswires

a month ago

Benchmark Adjusts Price Target on Halozyme Therapeutics to $60 From $50, Maintains Buy Rating

MT Newswires

a month ago

Halozyme Therapeutics Says Roche's OCREVUS SC With ENHANZE Gets European Commission Approval

Halozyme Announces Roche's OCREVUS® SC with ENHANZE® Receives European Commission Approval for Relapsing and Primary Progressive Multiple Sclerosis

PR Newswire

a month ago

Halozyme Announces Roche's OCREVUS® SC with ENHANZE® Receives European Commission Approval for Relapsing and Primary Progressive Multiple Sclerosis

Halozyme Therapeutics (NASDAQ:HALO) shareholder returns have been stellar, earning 193% in 5 years

Simply Wall St.

a month ago

Halozyme Therapeutics (NASDAQ:HALO) shareholder returns have been stellar, earning 193% in 5 years

Halozyme Announces argenx Receives FDA Approval for VYVGART® Hytrulo Co-Formulated with ENHANZE® for Chronic Inflammatory Demyelinating Polyneuropathy

PR Newswire

a month ago

Halozyme Announces argenx Receives FDA Approval for VYVGART® Hytrulo Co-Formulated with ENHANZE® for Chronic Inflammatory Demyelinating Polyneuropathy

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Zacks

a month ago

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Here's Why Halozyme Therapeutics (HALO) is a Strong Value Stock

Zacks

a month ago

Here's Why Halozyme Therapeutics (HALO) is a Strong Value Stock

Why Is Kodiak Sciences (KOD) Down 26.2% Since Last Earnings Report?

Zacks

a month ago

Why Is Kodiak Sciences (KOD) Down 26.2% Since Last Earnings Report?

Insider Sale: Director Matthew Posard Sells Shares of Halozyme Therapeutics Inc (HALO)

GuruFocus.com

a month ago

Insider Sale: Director Matthew Posard Sells Shares of Halozyme Therapeutics Inc (HALO)

MT Newswires

a month ago

Halozyme Therapeutics Insider Sold Shares Worth $1,006,300, According to a Recent SEC Filing

Allogene Therapeutics (ALLO) Down 13.9% Since Last Earnings Report: Can It Rebound?

Zacks

a month ago

Allogene Therapeutics (ALLO) Down 13.9% Since Last Earnings Report: Can It Rebound?

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Downgraded by Piper Sandler

Insider Monkey

a month ago

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Downgraded by Piper Sandler

Halozyme Therapeutics (HALO) is a Top-Ranked Momentum Stock: Should You Buy?

Zacks

a month ago

Halozyme Therapeutics (HALO) is a Top-Ranked Momentum Stock: Should You Buy?

Halozyme Therapeutics Scores RS Rating Jump To 91

Investor's Business Daily

2 months ago

Halozyme Therapeutics Scores RS Rating Jump To 91

MT Newswires

2 months ago

Wells Fargo Adjusts Price Target on Halozyme Therapeutics to $58 From $48, Maintains Overweight Rating

MT Newswires

2 months ago

HC Wainwright Raises Price Target on Halozyme Therapeutics to $65 From $50, Maintains Buy Rating

Halozyme (HALO) Raises 2024 Financial Guidance, Stock Up 13%

Zacks

2 months ago

Halozyme (HALO) Raises 2024 Financial Guidance, Stock Up 13%

MT Newswires

2 months ago

Piper Sandler Downgrades Halozyme Therapeutics to Neutral From Overweight, Adjusts Price Target to $51 From $48

"Green Energy" Brings Charging Piles to Mountain Villages

PR Newswire

2 months ago

"Green Energy" Brings Charging Piles to Mountain Villages

Global UV-Curable Adhesives Market Report 2024: Rising Demand in Electronics and Packaging Drives UV-Curable Adhesives Market to $605.4 Million by 2032

GlobeNewswire

2 months ago

Global UV-Curable Adhesives Market Report 2024: Rising Demand in Electronics and Packaging Drives UV-Curable Adhesives Market to $605.4 Million by 2032

Exploring James Halstead And Two More Top Dividend Stocks In The UK

Simply Wall St.

2 months ago

Exploring James Halstead And Two More Top Dividend Stocks In The UK

Omega Pacific Receives OTCQB Approval

ACCESSWIRE

2 months ago

Omega Pacific Receives OTCQB Approval

If You'd Invested $1,000 in Nvidia Stock 5 Years Ago, Here's How Much You'd Have Today

Motley Fool

2 months ago

If You'd Invested $1,000 in Nvidia Stock 5 Years Ago, Here's How Much You'd Have Today

Global Cloud ITSM Market Forecast Report 2024-2029, with Case Studies of Algar Tech, Grupo Moura, Deutsche Telekom, Opentext and Freshworks

GlobeNewswire

2 months ago

Global Cloud ITSM Market Forecast Report 2024-2029, with Case Studies of Algar Tech, Grupo Moura, Deutsche Telekom, Opentext and Freshworks

Stock market today: Asian stocks are mixed ahead of key U.S. jobs data

Associated Press Finance

2 months ago

Stock market today: Asian stocks are mixed ahead of key U.S. jobs data

Insider Sale: Director Mark Beck Sells Shares of Owens & Minor Inc (OMI)

GuruFocus.com

2 months ago

Insider Sale: Director Mark Beck Sells Shares of Owens & Minor Inc (OMI)

MT Newswires

2 months ago

Update: Halozyme Therapeutics Lifts 2024 Guidance -- Shares Surge

Halozyme Therapeutics (HALO) Up 8.7% Since Last Earnings Report: Can It Continue?

Zacks

2 months ago

Halozyme Therapeutics (HALO) Up 8.7% Since Last Earnings Report: Can It Continue?

Halozyme's (HALO) ENHANZE Product Gets New Patent Grant in EU

Zacks

2 months ago

Halozyme's (HALO) ENHANZE Product Gets New Patent Grant in EU

MT Newswires

2 months ago

Halozyme Therapeutics Lifts 2024 Guidance; Shares Rise Pre-Bell

Halozyme Raises Full Year 2024 Financial Guidance and Updates 5-Year Financial Outlook

PR Newswire

2 months ago

Halozyme Raises Full Year 2024 Financial Guidance and Updates 5-Year Financial Outlook

MT Newswires

2 months ago

Halozyme Therapeutics Gets European Patent for Enhanze Drug Delivery Platform

Halozyme Announces Issuance of New European Patent for ENHANZE® Drug Delivery Platform

PR Newswire

2 months ago

Halozyme Announces Issuance of New European Patent for ENHANZE® Drug Delivery Platform

Halozyme to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

PR Newswire

2 months ago

Halozyme to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Zacks

2 months ago

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Why Halozyme Therapeutics (HALO) is a Top Value Stock for the Long-Term

Zacks

2 months ago

Why Halozyme Therapeutics (HALO) is a Top Value Stock for the Long-Term

MT Newswires

2 months ago

Halozyme Therapeutics Insider Sold Shares Worth $905,480, According to a Recent SEC Filing

Halozyme Announces Bristol Myers Squibb Received Updated Action Date from the U.S. Food and Drug Administration for Subcutaneous Nivolumab Co-Formulated with ENHANZE®

PR Newswire

2 months ago

Halozyme Announces Bristol Myers Squibb Received Updated Action Date from the U.S. Food and Drug Administration for Subcutaneous Nivolumab Co-Formulated with ENHANZE®

Here's Why Halozyme Therapeutics (HALO) is a Strong Momentum Stock

Zacks

2 months ago

Here's Why Halozyme Therapeutics (HALO) is a Strong Momentum Stock

Halozyme Therapeutics Stock Earns IBD Stock Rating Upgrade, Hitting 80-Plus RS Rating

Investor's Business Daily

2 months ago

Halozyme Therapeutics Stock Earns IBD Stock Rating Upgrade, Hitting 80-Plus RS Rating

Here's Why Halozyme Therapeutics (HALO) is a Strong Growth Stock

Zacks

2 months ago

Here's Why Halozyme Therapeutics (HALO) is a Strong Growth Stock

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Zacks

2 months ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Biotech Stocks To Watch: Halozyme Actionable Now After Earnings-Fueled Breakout

Investor's Business Daily

3 months ago

Biotech Stocks To Watch: Halozyme Actionable Now After Earnings-Fueled Breakout

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q1 2024 Earnings Call Transcript

Insider Monkey

3 months ago

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q1 2024 Earnings Call Transcript

Halozyme's (HALO) Q1 Earnings Beat, Revenues Lag Estimates

Zacks

3 months ago

Halozyme's (HALO) Q1 Earnings Beat, Revenues Lag Estimates

Halozyme to Participate in Upcoming Investor Conferences

PR Newswire

3 months ago

Halozyme to Participate in Upcoming Investor Conferences

Thomson Reuters StreetEvents

3 months ago

Q1 2024 Halozyme Therapeutics Inc Earnings Call

GuruFocus.com

3 months ago

Halozyme Therapeutics Inc (HALO) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth ...

Halozyme Therapeutics (HALO) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Zacks

3 months ago

Halozyme Therapeutics (HALO) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

GuruFocus.com

3 months ago

Halozyme Therapeutics Q1 2024 Earnings: Misses EPS Estimates but Shows Revenue Growth

MT Newswires

3 months ago

Halozyme Therapeutics Q1 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Reaffirmed

Halozyme Therapeutics (HALO) Q1 Earnings Beat Estimates

Zacks

3 months ago

Halozyme Therapeutics (HALO) Q1 Earnings Beat Estimates

Associated Press Finance

3 months ago

Halozyme Therapeutics: Q1 Earnings Snapshot

HALOZYME REPORTS FIRST QUARTER 2024 FINANCIAL AND OPERATING RESULTS

PR Newswire

3 months ago

HALOZYME REPORTS FIRST QUARTER 2024 FINANCIAL AND OPERATING RESULTS

Halozyme Therapeutics (HALO) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates

Zacks

3 months ago

Halozyme Therapeutics (HALO) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates

How Novo-Catalent Deal Affects Halozyme (HALO)?

Insider Monkey

3 months ago

How Novo-Catalent Deal Affects Halozyme (HALO)?

Halozyme Therapeutics (HALO) Earnings Expected to Grow: Should You Buy?

Zacks

3 months ago

Halozyme Therapeutics (HALO) Earnings Expected to Grow: Should You Buy?

Mahesh Krishnan Elected to Halozyme's Board of Directors

PR Newswire

3 months ago

Mahesh Krishnan Elected to Halozyme's Board of Directors

Why Halozyme Therapeutics (HALO) is a Top Growth Stock for the Long-Term

Zacks

3 months ago

Why Halozyme Therapeutics (HALO) is a Top Growth Stock for the Long-Term

Argus Research

3 months ago

HALO: Raising target price to $41.00

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

Zacks

3 months ago

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

Halozyme to Report First Quarter 2024 Financial and Operating Results

PR Newswire

3 months ago

Halozyme to Report First Quarter 2024 Financial and Operating Results

Halozyme Therapeutics (HALO) is an Incredible Growth Stock: 3 Reasons Why

Zacks

3 months ago

Halozyme Therapeutics (HALO) is an Incredible Growth Stock: 3 Reasons Why

Halozyme Therapeutics (HALO) Upgraded to Buy: Here's What You Should Know

Zacks

3 months ago

Halozyme Therapeutics (HALO) Upgraded to Buy: Here's What You Should Know

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Zacks

4 months ago

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Halozyme Therapeutics (HALO) is a Top-Ranked Value Stock: Should You Buy?

Zacks

4 months ago

Halozyme Therapeutics (HALO) is a Top-Ranked Value Stock: Should You Buy?

Is Now The Time To Put Halozyme Therapeutics (NASDAQ:HALO) On Your Watchlist?

Simply Wall St.

4 months ago

Is Now The Time To Put Halozyme Therapeutics (NASDAQ:HALO) On Your Watchlist?

Mirum Pharmaceuticals (MIRM) Down 12.5% Since Last Earnings Report: Can It Rebound?

Zacks

4 months ago

Mirum Pharmaceuticals (MIRM) Down 12.5% Since Last Earnings Report: Can It Rebound?

Why Is Denali Therapeutics (DNLI) Up 2.8% Since Last Earnings Report?

Zacks

4 months ago

Why Is Denali Therapeutics (DNLI) Up 2.8% Since Last Earnings Report?

Fate Therapeutics (FATE) Down 8% Since Last Earnings Report: Can It Rebound?

Zacks

4 months ago

Fate Therapeutics (FATE) Down 8% Since Last Earnings Report: Can It Rebound?

Why Is Halozyme Therapeutics (HALO) Up 5.3% Since Last Earnings Report?

Zacks

4 months ago

Why Is Halozyme Therapeutics (HALO) Up 5.3% Since Last Earnings Report?

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Zacks

4 months ago

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Here's Why Halozyme Therapeutics (HALO) is a Strong Value Stock

Zacks

4 months ago

Here's Why Halozyme Therapeutics (HALO) is a Strong Value Stock

Insider Sell: SVP, Chief Technical Officer Michael Labarre Sells 20,000 Shares of Halozyme ...

GuruFocus.com

4 months ago

Insider Sell: SVP, Chief Technical Officer Michael Labarre Sells 20,000 Shares of Halozyme ...

Should You Hold Halozyme Therapeutics (HALO)?

Insider Monkey

5 months ago

Should You Hold Halozyme Therapeutics (HALO)?

Insider Sell: SVP, Chief Technical Officer Michael Labarre Sells 20,000 Shares of Halozyme ...

GuruFocus.com

5 months ago

Insider Sell: SVP, Chief Technical Officer Michael Labarre Sells 20,000 Shares of Halozyme ...

Halozyme to Participate in Upcoming Investor Conferences

PR Newswire

5 months ago

Halozyme to Participate in Upcoming Investor Conferences

Analyst Estimates: Here's What Brokers Think Of Halozyme Therapeutics, Inc. (NASDAQ:HALO) After Its Full-Year Report

Simply Wall St.

5 months ago

Analyst Estimates: Here's What Brokers Think Of Halozyme Therapeutics, Inc. (NASDAQ:HALO) After Its Full-Year Report

Halozyme Therapeutics Full Year 2023 Earnings: EPS Beats Expectations

Simply Wall St.

5 months ago

Halozyme Therapeutics Full Year 2023 Earnings: EPS Beats Expectations

Halozyme (HALO) Q4 Earnings Match Estimates, Revenues Lag

Zacks

5 months ago

Halozyme (HALO) Q4 Earnings Match Estimates, Revenues Lag

Share on Social Networks: